Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy.

NEs-Exos is confirmed to have neutrophil-like chemotactic function and BBB penetration and represents a promising chemotherapeutic approach for clinical treatment of glioma and other solid tumor or brain diseases.